Raza Marium M, Zaslansky Ruth, Gordon Debra B, Wildisen Jeanne M, Komann Marcus, Stamer Ulrike M, Langford Dale J
Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA.
Department of Anesthesiology, University Hospital, 07747 Jena, Germany.
J Clin Med. 2021 Apr 27;10(9):1887. doi: 10.3390/jcm10091887.
Acute postoperative pain is associated with adverse short and long-term outcomes among women undergoing surgery for breast cancer. Previous studies identified preexisting pain as a predictor of postoperative pain, but rarely accounted for pain location or chronicity. This study leveraged a multinational pain registry, PAIN OUT, to: (1) characterize patient subgroups based on preexisting chronic breast pain status and (2) determine the association of preexisting chronic pain with acute postoperative pain-related patient-reported outcomes and opioid consumption following breast cancer surgery. The primary outcome was a composite score comprising the mean of pain intensity and pain interference items from the International Pain Outcomes Questionnaire. The secondary outcome was opioid consumption in the recovery room and ward. Among 1889 patients, we characterized three subgroups: no preexisting chronic pain ( = 1600); chronic preexisting pain elsewhere ( = 128) and; chronic preexisting pain in the breast with/without pain elsewhere ( = 161). Controlling for covariates, women with preexisting chronic breast pain experienced more severe acute postoperative pain and pain interference (β = 1.0, 95% CI = 0.7-1.3, < 0.001), and required higher doses of opioids postoperatively (β = 2.7, 95% CI = 0.6-4.8, = 0.013). Preexisting chronic breast pain may be an important risk factor for poor pain-related postoperative outcomes. Targeted intervention of this subgroup may improve recovery.
接受乳腺癌手术的女性术后急性疼痛与不良的短期和长期预后相关。既往研究将术前存在的疼痛视为术后疼痛的预测因素,但很少考虑疼痛部位或慢性疼痛情况。本研究利用一个跨国疼痛登记系统PAIN OUT来:(1)根据术前存在的慢性乳房疼痛状况对患者亚组进行特征描述,以及(2)确定术前存在的慢性疼痛与乳腺癌手术后急性术后疼痛相关的患者报告结局及阿片类药物消耗之间的关联。主要结局是一个综合评分,包括国际疼痛结局问卷中疼痛强度和疼痛干扰项目的平均值。次要结局是恢复室和病房中的阿片类药物消耗。在1889例患者中,我们确定了三个亚组:无术前存在的慢性疼痛(n = 1600);术前存在其他部位的慢性疼痛(n = 128);术前存在乳房慢性疼痛伴或不伴有其他部位疼痛(n = 161)。在控制协变量后,术前存在慢性乳房疼痛的女性术后急性疼痛和疼痛干扰更严重(β = 1.0,95%CI = 0.7 - 1.3,P < 0.001),且术后需要更高剂量的阿片类药物(β = 2.7,95%CI = 0.6 - 4.8,P = 0.013)。术前存在的慢性乳房疼痛可能是术后疼痛相关不良结局的一个重要危险因素。对该亚组进行有针对性的干预可能会改善恢复情况。